Correlates of intent to be vaccinated against human papillomavirus: an exploratory study of college-aged women
Richard Crosby A B C G , Nancy Schoenberg D , Claudia Hopenhayn A , Greg Moore A E and William Melhan FA College of Public Health, University of Kentucky, 121 Washington Ave, Lexington, KY 40506-0003, USA.
B Rural Center for AIDS/STD Prevention, 801 East 7th St, Bloomington, IN 47405, USA.
C The Kinsey Institute for Research in Sex, Gender, and Reproduction, Indiana University, Morrison Hall, Bloomington, IN 47405, USA.
D Department of Behavioral Sciences, College of Medicine Office Building, University of Kentucky, Lexington, KY 40536-0086, USA.
E B163 Kentucky Clinic, 740 S. Limestone Dr, University of Kentucky, Lexington, KY 40536-0284, USA.
F Caudill Health Clinic, 112 Allie Young Hall, Morehead University, Morehead, KY 40351, USA.
G Corresponding author. Email: crosby@uky.edu
Sexual Health 4(1) 71-73 https://doi.org/10.1071/SH06046
Submitted: 25 July 2006 Accepted: 17 January 2007 Published: 26 February 2007
Abstract
This study identified correlates of human papillomavirus (HPV) vaccine acceptance among college-aged women. Data were collected by self-administered questionnaire. In multivariate analyses, women having vaginal sex (past 12 months) were nearly four times more likely to indicate acceptance (P = 0.0001). Those reporting ever having a sexually transmissible infection (STI; P = 0.03) and those indicating ever having an abnormal Pap test (P = 0.03) were more likely to indicate acceptance. Thus, three forms of ‘exposure’ (having sex, having an STI or abnormal Pap) may be linked to vaccine acceptance among young women attending universities. The findings suggest that opportunities may exist for clinic-based HPV vaccine promotion among this population of women.
Additional keywords: cervical cancer, prevention, sexual behaviour.
[1]
[2] Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human Papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189 12–9.
| Crossref | GoogleScholarGoogle Scholar | PubMed | [verified 3 July 2006].
[9] Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348 518–27.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[10] Zimet GD. Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health 2005; 37 S17–23.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[11] Zimet GD, Mays RM, Fortenberry JD. Vaccines against sexually transmitted infections: promise and problems of the magic bullets for prevention and control. Sex Transm Dis 2000; 27 49–52.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[12] Kahn JA, Rosenthal SL, Hamann T, Bernstein DI. Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS 2003; 14 300–6.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[13] Boehner CW, Howe SR, Bernstein DI, Rosenthal SL. Viral sexually transmitted disease vaccine acceptability among college students. Sex Transm Dis 2003; 30 774–8.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
